Dwight Moxie, CLO & GC at Revance Therapeutics, Inc. (RVNC), sold 11,394 shares at $5.04 ($58K) on 2024-03-18, disclosed to the SEC on 2024-03-19.
Seasonal sale ($58k) by CLO & GC — this insider has traded RVNC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.31 | 3,269 | $17K | 29.8% |
| 2 | $5.04 | 8,125 | $41K | 70.2% |
| Total | $5.12 avg | 11,394 | $58K | 100% |
| Filing → |
| RVNC | SELL | 2023-03-09 | $1.2M | — | Filing → |
| RVNC | SELL | 2022-09-16 | $298K | — | Filing → |
| RVNC | SELL | 2021-09-28 | $50K | — | Filing → |